134 related articles for article (PubMed ID: 6727693)
1. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
Christiansen C; Christensen MS; Grande P; Transbøl I
Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
[TBL] [Abstract][Full Text] [Related]
2. Effect on lipoproteins of Trisequens, a combined hormone preparation.
Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Jensen J; Christiansen C
Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
[TBL] [Abstract][Full Text] [Related]
4. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
Owens D; Collins PB; Johnson A; Tomkin GH
Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
[TBL] [Abstract][Full Text] [Related]
5. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
Jensen J; Nilas L; Christiansen C
Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
[TBL] [Abstract][Full Text] [Related]
6. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
7. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Jensen J; Riis BJ; Strøm V; Christiansen C
Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
[TBL] [Abstract][Full Text] [Related]
8. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
Mattsson LA; Cullberg G; Samsioe G
Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
[TBL] [Abstract][Full Text] [Related]
9. A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women.
Farish E; Fletcher CD; Hart DM; Kitchener H; Sharpe GL
Clin Chim Acta; 1983 Aug; 132(2):193-8. PubMed ID: 6577991
[TBL] [Abstract][Full Text] [Related]
10. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
[TBL] [Abstract][Full Text] [Related]
12. Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Fåhraeus L; Larsson-Cohn U; Wallentin L
Acta Endocrinol (Copenh); 1982 Dec; 101(4):597-602. PubMed ID: 7158232
[TBL] [Abstract][Full Text] [Related]
13. Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in peri-menopausal women.
Blumenfeld Z; Aviram M; Brook GJ; Brandes JM
Maturitas; 1983 Aug; 5(2):77-83. PubMed ID: 6579340
[TBL] [Abstract][Full Text] [Related]
14. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
Vilska S; Punnonen R; Rauramo L
Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
[TBL] [Abstract][Full Text] [Related]
15. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
Hirvonen E; Mälkönen M; Manninen V
N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
18. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
19. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Mc Manus J; Mc Eneny J; Thompson W; Young IS
Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
[TBL] [Abstract][Full Text] [Related]
20. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Christiansen C; Riis BJ
Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]